glp-1 receptor agonists blindness risk A nurse lost her eyesight while on drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S GLP-1 medications and eye problem
Description
Curr Cardiovasc Risk Rep 19 , 11 (2025)
[DOI] [PubMed] [Google Scholar] 868.Mansur S.A., Mieczkowska A., Flatt P.R., Chappard D., Irwin N., Mabilleau G

Short-acting agents undergo renal clearance, so they require once-daily (lixisenatide) or twice-daily (exenatide BD) dosing

Growth hormone secretagogues like CJC-1295/Ipamorelin or Sermorelin address lean mass preservation during weight loss
[DOI] [PubMed] [Google Scholar] 39.Petrou M, et al

Longo DL, ed
